More Mayne Pharma Group Ltd. news
Mayne Pharma Group Ltd.ASX: MYX

2024 Half Year Media Release

Feb 25, 2024 at 9:41 PM EST · Issued by Mayne Pharma Group Ltd.

Filed with ASX · Feb 25, 2024 at 9:41 PM EST · 6 pages · English

On 6ix: 6ix.com/news/2024-half-year-media-release

Watch Mayne Pharma's latest callMayne Pharma Group (ASX:MYX) Q4 2026 Earnings Call · Replay · Aug 26↗

Mayne Pharma Group Ltd. on 6ix

In the deck

  • Mayne Pharma Group — Investor Presentation (February 2024)29 slidesFeb 26, 2024

Story so far

  • 2023 Full Year Results Media ReleaseAug 31, 2023
  • 2023 Half Year Investor PresentationFeb 28, 2023
  • 2022 Half Year Media ReleaseFeb 28, 2023

Earlier from Mayne Pharma

  • Mayne Pharma to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceDec 29, 2023
  • Issuance of additional US Patent for NEXTSTELLISNov 5, 2023
  • Mayne Pharma provides update on first quarter 2024 trading and outlookOct 19, 2023
  • Mayne Pharma provides update on 1Q FY24 trading and outlookOct 17, 2023
  • 2023 Full Year Results Investor PresentationAug 30, 2023

Later from Mayne Pharma

  • Mayne Pharma reports 1H FY24 results with A 43% increase in revenue to A$188 million and $8 million underlying EBITDAFeb 27, 2024
  • Notification of buy-back - MYXMay 23, 2024
  • Class action settlementJul 1, 2024
  • Appendix 4E and Full Year Statutory AccountsAug 22, 2024
  • 2024 Full Year Results Media ReleaseAug 22, 2024
All Mayne Pharma news releases↗

Follow Mayne Pharma into a list and get an email when it puts out news.

Follow Mayne Pharma
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer